Skip to main content
SpringerLink
Log in

Latent HSV-1 infection in mice immunized with a zwitterionic detergent-extracted HSV-1 antigen preparation

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

A HSV-1 antigen preparation obtained by zwitterionic detergent-extraction of HSV-1 infected Vero cells was investigated for its ability to protect mice against establishment of latent infection in the trigeminal ganglion following HSV-1 challenge by ear scarification. The antigen preparation was shown to induce antibody production and correlation between pre-challenge antibody level and establishment of latency was found.

Although immunization did not reduce the overall incidence of ear erythema following challenge the duration of erythema was significantly decreased. Latency in the trigeminal ganglion was also significantly reduced in vaccinated mice and in addition, a correlation was found between the duration of erythema and latency, there being significantly more latent infections in mice with erythema of three or more days duration, than in those with erythema lasting less than three days.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allen WP, Rapp F (1982) Concept review of genital herpes vaccines. J Infect Dis 145: 413–421

    Google Scholar 

  2. Blyth WA, Harbour DA, Hill TJ (1984) Pathogenesis of zosteriform spread of herpes simplex virus in the mouse. J Gen Virol 65: 1477–1486

    Google Scholar 

  3. Berman PW (1988) Prospects for vaccines for herpes simplex virus. J Am Acad Dermatol 18: 226–232

    Google Scholar 

  4. Berman PW, Vogt PE, Gregory T, Lasky LA, Kern ER (1988) Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent and latent genital infections with herpes simplex virus Type 2 in guinea-pigs. J Infect Dis 157: 897–902

    Google Scholar 

  5. Bernstein DI, Stanberry LR, Kappes JC, Burke RL, Myers MG (1988) Antibody to herpes simplex virus (HSV) ICP-35 proteins after HSV challenge of animals immunised with HSV subunit vaccines J Infect Dis 157: 1178–1186

    Google Scholar 

  6. Cappel R, de Cuyper F, Rickaert F (1980) Efficacy of nucleic acid free herpetic subunit vaccine. Arch Virol 65: 15–23

    Google Scholar 

  7. Corey L, Giddings R, Remington ML, Winter C (1986) Concepts in the development of an effective HSV vaccine. In: Lopez C, Roizman B (eds) Human herpesvirus infections: pathogenesis, diagnosis and treatment. Raven Press, New York, pp 259–275

    Google Scholar 

  8. Cremer KJ, Mackett M, Wohlenberg C, Notkins AL, Moss B (1985) Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 228: 737–740

    Google Scholar 

  9. Dix RD, Mills J (1985) Acute and latent herpes simplex virus neurological disease in mice immunised with purified virus-specific glycoproteins gB or gD. J Med Virol 17: 9–18

    Google Scholar 

  10. Erturk M, Jennings R, Hockley D, Potter CW (1989) Antibody responses and protection in mice immunised with HSV-1 antigen ISCOM preparation J Gen Virol 70: 2149–2155.

    Google Scholar 

  11. Erturk M, Welch MJ, Jennings R, Phillpotts RJ (1989) Protection and serum antibody responses in guinea-pigs and mice immunised with HSV-1 antigen preparations obtained using different detergents. Vaccine (in press)

  12. Harbour DA, Hill TJ, Blyth WA (1983) Recurrent herpes simplex in the mouse: inflammation in the skin and activation of virus in the ganglia following peripheral stimulation. J Gen Virol 64: 1491–1498

    Google Scholar 

  13. Hill TJ, Altmann DM, Blyth WA, Harbour DA, Whitby A (1984) Herpes simplex virus latency. Clin Dermatol 2: 46–55

    Google Scholar 

  14. Hill TJ, Field HJ, Blyth WA (1975) Acute and recurrent infection with herpes simplex virus in the mouse: model for studying latency and recurrent disease. J Gen Virol 28: 341–353

    Google Scholar 

  15. Jennings R, Quasim T, Sharrard RM, Hockley D, Potter CW (1988) Zwitterionic detergent solubilisation of HSV-1 surface antigens. Arch Virol 98: 137–153

    Google Scholar 

  16. Kapoor AK, Nash AA, Wildy P, Phelan J, McLean CS, Field HJ (1982) Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity. J Gen Virol 60: 225–233

    Google Scholar 

  17. Kino Y, Hayashi Y, Hayashida I, Mori R (1982) Dissemination of herpes simplex virus in nude mice after intracutaneous inoculation and effect of antibody on the course of infection. J Gen Virol 63: 475–479

    Google Scholar 

  18. Kitces EN, Morahan PS, Tew JG, Murray BK (1977) Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine. Infect Immun 16: 955–960

    Google Scholar 

  19. Klein RJ, Buimovivi-Klein E, Moser H, Moucha R, Hilfenhaus J (1981) Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice. Arch Virol 68: 73–80

    Google Scholar 

  20. Lowry O, Rosebrough NJ, Farr AL, Randall TJ (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193: 265–275

    Google Scholar 

  21. Meignier B, Jourdier T, Norrild B, Pereira L, Roizman B (1987) Immunisation of experimental animals with reconstituted glycoprotein mixtures of Herpes simplex virus 1 and 2: protection against challenge with virulent virus. J Infect Dis 155: 921–930

    Google Scholar 

  22. Mukhlis FA, Jennings R, Stephenson TJ, Quasim T, Potter CW (1986) Characterisation and immunogenicity of HSV-1 antigens obtained following zwitterionic detergent treatment. Vaccine 4: 191–196

    Google Scholar 

  23. Nilheden E, Jeannson S, Vahlne A (1983) Typing of Herpes simplex virus by an enzymelinked immunosorbent assay with monoclonal antibodies. J Clin Microbiol 17: 677–680

    Google Scholar 

  24. Olofsson S, Sjoblom I, Lundstrom M, Jeansson S, Lycke E (1983) Glycoprotein C of Herpes simplex virus Type 1: characterisation of O-linked oligosaccharides. J Gen Virol 64: 2735–2747

    Google Scholar 

  25. Rawls WE, Iwamoto K, Adam E, Melnick JC (1970) Measurement of antibodies to Herpesvirus types 1 and 2 in human sera. J Immunol 104: 599–606

    Google Scholar 

  26. Rooney JF, Wohlenberg C, Cremer KJ, Moss B, Notkins AL (1988) Immunisation with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination. J Virol 62: 1530–1534

    Google Scholar 

  27. Slicktova V, Kutinova L, Vonka V (1980) Immunogenicity of subviral herpes simplex virus type 1 preparation: protection of mice against intradermal challenge with type 1 and type 2 viruses. Arch Virol 66: 207–214

    Google Scholar 

  28. Stanberry LR, Bernstein DI, Burke RL, Pachl C, Myers MG (1987) Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. J Infect Dis 155: 914–920

    Google Scholar 

  29. Thomson TA, Hilfenhaus J, Moser H, Morahan PS (1983) Comparison of effects of adjuvants on efficacy of virion envelope herpes simplex virus vaccine against labial infection of Balb/c mice. Infect Immun 41: 556–562

    Google Scholar 

  30. Wildy P (1986) Herpesvirus. Intervirology 25: 117–140

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Virology, University of Sheffield Medical School, Sheffield, England

    A. Al-Ghamdi, R. Jennings, H. Bentley & C. W. Potter

Authors
  1. A. Al-Ghamdi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Jennings
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Bentley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. W. Potter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Ghamdi, A., Jennings, R., Bentley, H. et al. Latent HSV-1 infection in mice immunized with a zwitterionic detergent-extracted HSV-1 antigen preparation. Archives of Virology 108, 19–31 (1989). https://doi.org/10.1007/BF01313739

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01313739

Keywords

Search

Navigation